BBRI has released its bank-only Aug-25 results, which came in behind our projections (and Bloomberg consensus). YTD Aug-25 results highlighted the ongoing challenges faced by the bank. We think these will persist for the remaining 2025F (at the very least). On an YTD Aug-25 basis, the bank reported a profit of IDR32.6tn (-10% y-y). The large profit drop resulted not only from its operating level but also from persistently high credit costs (reflecting the ongoing issues with the bank’s loan qualities). The large decline also reflects the absence of non-loan reversal related to one of the construction costs in YTD Aug-25, while in YTD Aug-24, the bank reported a reversal of ~IDR3.4tn. Adjusting for this, headline profit would have been flat y-y.

Still, such a profit drop reflects persistently high estimated write-off rates and likely ongoing NPL formations. Indeed, we estimate BBRI’s 12MMA monthly write-off rate stood at ~3.5% in Aug-25. So far, the write-offs do not seem to be abating, which would mean elevated credit costs (CoC) for BBRI. We think the two areas that witnessed high write-off rates and/or NPL formations rates were micro and small loan portfolios. Given the above, we think BBRI’s medium-term earnings growth trajectory will remain subdued. Our projected 3-year (2024-27F) consolidated earnings CAGR is ~0.4%. We see any near-term weakness as a buying opportunity.  

Longer term, we retain our view that BBRI might need to start tapping into other segments as deposit growth in its mass-market segment is structurally slower than other segments given that deposit growth in the mass-market segment has been ~2-3% y-y — suggesting that loan growth for this segment will be <5% pa.

Refer to tables below for balance sheet details.

Valuation and risks

Our TP of IDR5,000 is based on DuPont analysis, with a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 9.3%, beta 0.85x and a CAR-adjusted ROAE of 18.0%. We also use 2025F book as reference. The implied multiples at our TP would be 2.3x 2025F book and 12.5x 2025F earnings. Risks are worsening macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition, which could increase funding costs, worsening credit quality which would raise credit costs, and higher opex. Changes in management might affect the bank’s write-off policies and thus, credit costs. This would ultimately affect the bank’s near-term earnings.

Fig. 1: BBRI YTD y-y performance %

Fig. 4: BBRI - 12MMA CoC vs 12MMA WO % Still elevated WO rates

Fig. 5: BBRI - LLR vs 12MMA WO %

INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general. 

GENERAL DISCLOSURE/DISCLAIMER 
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).

This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.

The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.

This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.

ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views.  The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.

RESTRICTIONS ON DISTRIBUTION

By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations. 

Erwin Wijaya (erwin.wijaya@verdhana.id)